Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q2 FY26 Earnings Presentation
22 slides from Aarti Industries's earnings presentation, Nov 6, 2025
Slide 1: Cover letter to stock exchanges
November 6, 2025 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. BSE CODE : 524
Slide 2: Q2 FY26 Performance Update
A Legacy of Q2 FY26 Excellence Performance Update A Future of 6th Nov, 2025 Possibilities
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Index
Company overview Index Q2 FY26 Highlights Future Outlook and Roadmap
Slide 5: Index: Company overview
Company overview Index Q2 FY26 Highlights Future Outlook and Roadmap
Slide 6: Aarti Industries at a Glance
Aarti Industries at a Glance Established by first generation technocrats in 1984 Benzene based Feedstock Assurance and Downstream Products Supply Integrated operations and high-cost optimization Toluene based Technology Sharing Key value chains include Nitro Chloro Benzenes, Di- Downstream Products
Slide 7: Our Ethos
Our Ethos AIL VALUES PURPOSE Right Chemistry for a Brighter Tomorrow VISION To emerge as a Global Partner of Choice for leading consumers of speciality chemicals and intermediates MISSION Delighted Stakeholders CARE INTEGRITY EXCELLENCE 6
Slide 8: Index: Q2 FY26 Highlights
Company overview Index Q2 FY26 Highlights Future Outlook and Roadmap
Slide 9: Business Highlights – Q2 FY26
Business Highlights – Q2 FY26 Variable and Fixed cost optimization Ramp up in MMA capacity utilisation with Active efforts underway to mitigate US initiatives progressing as expected improved gasoline - naphtha delta tariff impact, and still sustain volume supporting blending economics growth across
Slide 10: New Strategic Partnership: Long Term Chlorine Supply Agreement
New Strategic Partnership: Long Term Chlorine Supply Agreement Long-term strategic supply agreement Secures chlorine supply from DCM’s Chlor-Alkali plant to AIL’s upcoming Zone-IV (Jhagadia) facility Dedicated underground jacketed pipeline with precision engineering to ensure safe, reliable & enviro
Slide 11: Q2 & H1 FY26 Highlights (Consolidated)
Q2 & H1 FY26 Highlights (Consolidated) Revenue increased due to: YoY: 26%▲ QoQ: 21%▲ YoY: 44%▲ QoQ: 36%▲ YoY: 102%▲ QoQ: 150%▲ Increased volumes specifically for MMA 291 Benefits of Q1's deferred bulk shipments were 216 realized in Q2 106 Business Volumes 43 Energy Non-Energy YoY: 118% ▲ YoY: 17% ▲
Slide 12: Capacities and utilization trend for few major products
Capacities and utilization trend for few major products Capacity FY25 Q2 FY25 Q1 FY26 Q2 FY26 Q2 FY26 Product Groups Q-o-Q Y-o-Y (in KTPA) (kT) (kT) (kT) (kT) Utilization % NCB 108 85.3 19.0 21.7 21.5 -1% 13% 80% DCB 120 88.6 23.3 19.3 22.0 14% -6% 73% Hydrogenation 60 44.4 11.2 12.3 11.3 -8% 1% 75%
Slide 13: Revenue by End Use
Revenue by End Use Rs. crore1 8,046 1,786 1,867 2,250 Agrochemicals application showing steady volumes, but margins remain under pressure Agrochemicals & Fertilizers Higher volumes in energy application driven by favorable blending economics, expanded Dyes, Pigments and capacities and spill over of
Slide 14: Application wise market updates & business highlights (1/2)
Application wise market updates & business highlights (1/2) End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share 19% 43% Domestic Domestic / Exports Domestic 64% Export 36% 7% Export 93% • Vol
Slide 15: Application wise market updates & business highlights (2/2)
Application wise market updates & business highlights (2/2) Dyes, Pigments & Printing End Use Pharmaceuticals Polymer and additives Inks PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share 11% 10% 12% Export Domestic Domestic/Exports Domestic 73% Export 27%
Slide 16: Joint Ventures
Joint Ventures Augene Chemical Private Limited Joint venture for manufacturing and marketing of specialty chemicals with multiple downstream applications Combines the strengths of both partners who will supply essential raw materials to the JV Project execution is progressing well (expect commission
Slide 17: Index: Future Outlook and Roadmap
Company overview Index Q2 FY26 Highlights Future Outlook and Roadmap
Slide 18: Key EBITDA Growth Drivers in near term (FY26 - FY28)
Key EBITDA Growth Drivers in near term (FY26 - FY28) Cost Optimisation Volume and margin ramp-up CAPEX-led growth ₹ 150-200 crore ₹ 350-550 crore ₹ 300-450 crore ✔ Switching to Back Pressure Turbine to Acid, DCB & NCB value chain ✔ Pilot commissioned to fuel New improve Cogen ramp-up Product Develop
Slide 19: Growth Outlook – consistent with previous update
Growth Outlook – consistent with previous update EBITDA, ₹ Cr Consistent volume growth over 3 yrs driven by increased capacities 1800 - 2200 Operating leverages and cost optimisation initiatives to drive EBITDA growth beyond volume growth Capex for FY26 estimated to be around ₹ 1000 Cr Target EBITDA
Slide 20: Long term growth focus areas
Long term growth focus areas MPP and Zone 4 Commercialization • R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries • Chlorotoluene commissioning and ramp up will open up new opportunities in Agro and Pharma business segments New Growth Avenues
Slide 21: Certifications
~ Ww * Certifications O) exis ecovadis KF SUSTAINABILITY Sustainability Rating cs AList Responsible Care” APR 2025 ISO 45001:2018 2024 ‘UR COMMITMENT TO SUSTAINABILITY { SS TOGETHER Iso CDP QW’
Slide 22: Thank You
+91 22 6797 6666 Thank You investorrelations@aarti-industries.com